What are the main functions and effects of Alpelisib?
Alpelisib (Alpelisib)-Piqray is a selective phosphatidylinositol-3-kinase (PI3K) alpha inhibitor, mainly used for the treatment of breast cancer that targets specific molecular mutations. Its core mechanism of action is to block the growth and proliferation of cancer cells by inhibiting the PI3K signaling pathway, thereby delaying disease progression. The PI3K pathway is one of the key signaling mechanisms involved in cell growth, metabolism and survival in the human body. In many tumor types, this pathway is abnormally activated due to PIK3CA gene mutations, leading to excessive cell proliferation and increased drug resistance. Apelvis can target this critical node and provide more specific treatment options for patients with advanced or metastatic breast cancer.
The clinical positioning of Apelvis is mainly concentrated in patients with hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer, especially those who have progressed after endocrine therapy. When used in combination with fulvestrant (Fulvestrant), it can significantly delay the growth of tumors. Different from traditional chemotherapy, Apelvis is a targeted therapy drug. Its effect is more targeted, has relatively little impact on healthy cells, and is well tolerated. Research shows that it can effectively inhibit cancer cell signaling driven by PIK3CA mutations, enhance the sensitivity of tumor cells to endocrine therapy, and provide new treatment ideas for hormone receptor-positive breast cancer patients.
At the molecular level, Apelvis blocks the activity ofPI3Kα and inhibits the downstream Akt and mTOR pathways, thereby reducing the energy supply and protein synthesis of tumor cells and promoting cancer cells to enter an apoptotic state. This dual mechanism not only helps control tumor growth but also slows the development of drug tolerance. It is worth noting that the efficacy of apelvis is most significant in patients with clear PIK3CA mutations, which is also a representative case of the concept of precision medicine in tumor treatment.
Reference materials:https://www.piqray.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)